Health Populi October 6, 2023
Jane Sarasohn-Kahn

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” the CEO of Walmart US is quoted in Bloomberg. “Just less units, slightly less calories.”

With patients’ use GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro fast-rising in the pharmacy market, so are the concerns of companies that stock the-middle-of-the-grocery-store aisles for processed foods like sweet and salty snacks.

As the prospects for the drug companies who manufacture prescription drugs made for patients managing diabetes and obesity are on the uptick, the likes of the makers of Pringles and Oreos are in the throes of re-thinking and -making snack foods and other products that some consumers aren’t filling their...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Retailer
AI, Omnichannel and Social Commerce: Inside the 2024 D2C Transformation
How AI Is Quietly Transforming E-Commerce Search And Discovery
Walmart's '24 healthcare exit: 10 notes
What big retailers did in healthcare in 2024
How Trauma-Informed Design Principles Can Be Health-Ful for All of Us – Learning from IKEA

Share This Article